(Q38056543)

27 August 2017

title

Is there a place for coenzyme Q in the management of metabolic disorders associated with obesity? (English)

1 reference

27 August 2017

0 references

Florence M Sohet

1

1 reference

27 August 2017

Nathalie M Delzenne

series ordinal

2

1 reference

27 August 2017

publication date

25 September 2012

1 reference

27 August 2017

1 reference

27 August 2017

volume

70

1 reference

27 August 2017

issue

11

1 reference

27 August 2017

page(s)

631-641

1 reference

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

Inflammation and metabolic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

Inflammatory disease processes and interactions with nutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

Antioxidant and prooxidant properties of mitochondrial Coenzyme Q.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

The antioxidant role of coenzyme Q.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

Biochemical functions of coenzyme Q10

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

Metabolism and function of coenzyme Q.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

Discovery of ubiquinone (coenzyme Q) and an overview of function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

Coenzyme Q10: absorption, tissue uptake, metabolism and pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

The uptake and distribution of coenzyme Q10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

Influence of Coenzyme Q_{10} on release of pro-inflammatory chemokines in the human monocytic cell line THP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

Functions of coenzyme Q10 in inflammation and gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

Functional connections and pathways of coenzyme Q10-inducible genes: an in-silico study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

In Vitro Effects of the Reduced Form of Coenzyme Q(10) on Secretion Levels of TNF-alpha and Chemokines in Response to LPS in the Human Monocytic Cell Line THP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

Effects of Coenzyme Q10 on TNF-alpha secretion in human and murine monocytic cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

Anti-inflammatory effects of CoQ10 and colorless carotenoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

Neuroprotective Effects of Coenzyme Q10 at Rostral Ventrolateral Medulla Against Fatality During Experimental Endotoxemia in the Rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

Effects of dietary coenzyme Q10 supplementation on hepatic mitochondrial function and the activities of respiratory chain-related enzymes in ascitic broiler chickens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

Quercetin, coenzyme Q10, and L-canavanine as protective agents against lipid peroxidation and nitric oxide generation in endotoxin-induced shock in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

Effects of ubiquinol-10 on microRNA-146a expression in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

Immunomodulatory effects of L-carnitine and q10 in mouse spleen exposed to low-frequency high-intensity magnetic field

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

Naturally occurring antioxidant nutrients reduce inflammatory response in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

Hormones and antioxidant systems: role of pituitary and pituitary-dependent axes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

Regulation of ubiquinone metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

Coenzyme Q10 changes are associated with metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

The clinical use of HMG CoA-reductase inhibitors and the associated depletion of coenzyme Q10. A review of animal and human publications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

Evaluation of antioxidant systems (coenzyme Q10 and total antioxidant capacity) in morbid obesity before and after biliopancreatic diversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

Comparison of coenzyme Q10 plasma levels in obese and normal weight children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

Coenzyme Q as an antiadipogenic factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

Functioning of oxidative phosphorylation in liver mitochondria of high-fat diet fed rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

Adipose tissue proadipogenic redox changes in obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

Malondialdehyde and coenzyme Q10 in platelets and serum in type 2 diabetes mellitus: correlation with glycemic control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

Oxidative burden in prediabetic and diabetic individuals: evidence from plasma coenzyme Q(10).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

Effects of fenofibrate therapy on plasma ubiquinol-10 and ubiquinone-10 levels in Japanese patients with hyperlipidemia and type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

Daily profile of plasma %CoQ10 level, a biomarker of oxidative stress, in patients with diabetes manifesting postprandial hyperglycaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

Supplementation of coenzyme Q10 and alpha-tocopherol lowers glycated hemoglobin level and lipid peroxidation in pancreas of diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

Diabetes induces metabolic adaptations in rat liver mitochondria: role of coenzyme Q and cardiolipin contents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

Coadministration of coenzyme Q prevents rosiglitazone-induced adipogenesis in ob/ob mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

Beneficial effect of coenzyme Q10 on increased oxidative and nitrative stress and inflammation and individual metabolic components developing in a rat model of metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

Coenzyme Q10 supplementation lowers hepatic oxidative stress and inflammation associated with diet-induced obesity in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

The co-encapsulated antioxidant nanoparticles of ellagic acid and coenzyme Q10 ameliorates hyperlipidemia in high fat diet fed rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

Combined effect of coenzyme Q10 and fenofibrate on forearm microcirculatory function in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

Coenzyme Q10 improves blood pressure and glycaemic control: a controlled trial in subjects with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

Coenzyme Q(10) improves endothelial dysfunction of the brachial artery in Type II diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

Coenzyme Q10 improves endothelial dysfunction in statin-treated type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

Diabetes mellitus associated with 3243 mitochondrial tRNA(Leu(UUR)) mutation: clinical features and coenzyme Q10 treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

The effects of coenzyme Q10 treatment on maternally inherited diabetes mellitus and deafness, and mitochondrial DNA 3243 (A to G) mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

Unusual occurrence of intestinal pseudo obstruction in a patient with maternally inherited diabetes and deafness (MIDD) and favorable outcome with coenzyme Q10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

Effects of coenzyme Q10 treatment on antioxidant pathways in normal and streptozotocin-induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

Effect of coenzyme Q10 on catalase activity and other antioxidant parameters in streptozotocin-induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

CoQ10 therapy attenuates amyloid beta-peptide toxicity in brain mitochondria isolated from aged diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

Effects of antioxidants coenzyme Q10 and lipoic acid on interleukin-1 beta-mediated inhibition of glucose-stimulated insulin release from cultured mouse pancreatic islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

Coenzyme Q10 prevents high glucose-induced oxidative stress in human umbilical vein endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

Hemodynamic effects of fenofibrate and coenzyme Q10 in type 2 diabetic subjects with left ventricular diastolic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

Systematic review of effect of coenzyme Q10 in physical exercise, hypertension and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

Possible role of ubiquinone in the treatment of massive hypertriglyceridemia resistant to PUFA and fibrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

Role of coenzyme Q10 (CoQ10) in cardiac disease, hypertension and Meniere-like syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

Coenzyme Q10 in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

The role of oxidized phospholipids in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

Inhibition of LDL oxidation by ubiquinol-10. A protective mechanism for coenzyme Q in atherogenesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

A role for reduced coenzyme Q in atherosclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

The effect of pharmacological doses of different antioxidants on oxidation parameters and atherogenesis in hyperlipidaemic rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

Mclk1+/- mice are not resistant to the development of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

Dietary cosupplementation with vitamin E and coenzyme Q(10) inhibits atherosclerosis in apolipoprotein E gene knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

Distribution of antioxidants among blood components and lipoproteins: significance of lipids/CoQ10 ratio as a possible marker of increased risk for atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

Coenzyme Q--biosynthesis and functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

Coenzyme Q10 and statins: biochemical and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

Treatment of statin adverse effects with supplemental Coenzyme Q10 and statin drug discontinuation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

Molecular basis of statin-associated myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

Management of the patient with statin intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

Effect of coenzyme q10 on myopathic symptoms in patients treated with statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

Effect of coenzyme Q(10) supplementation on simvastatin-induced myalgia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

The role of coenzyme Q10 in statin-associated myopathy: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-4887.2012.00526.X

10.1111/J.1753-4887.2012.00526.X

21 January 2018

Identifiers

DOI

1 reference

27 August 2017

1 reference